Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 8, 2019. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-165-01
- Dosage Form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)
- Initial Posting
- Feb 8, 2019
Reason
Demand increase for the drug